The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China

Published:2016-03 Issue:2 Volume:39 Page:81-87
ISSN:0362-5664
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:

Author:

Chen Hongxi,Zhang Yan,Shi Ziyan,Feng Huiru,Yao Shaoli,Xie Jinglu,Zhou Hongyu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Clinical Neurology,Pharmacology

Reference40 articles.

1. The expanding range of autoimmune disorders of the nervous system.;Wildemann;Lancet Neurol,2013

2. The spectrum of neuromyelitis optica.;Wingerchuk;Lancet Neurol,2007

3. Neuromyelitis optica-AQP4: an update.;Benavente;Curr Rheumatol Rep,2011

4. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.;Lennon;Lancet,2004

5. The clinical course of neuromyelitis optica (Devics syndrome).;Wingerchuk;Neurology,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study;Immunological Medicine;2024-01-18

2. Can quantitative monitoring of B cells evaluate the efficacy of Rituximab in primary CNS demyelinating disorders?;Annals of Medical Science & Research;2024-01

3. An overview of neuromyelitis optica spectrum disorders;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024

4. Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma–inactivated protein 1 encephalitis: a prospective observational cohort study;Neurological Sciences;2023-08-15

5. A Clinical Approach to Existing and Emerging Therapeutics in Neuromyelitis Optica Spectrum Disorder;Current Neurology and Neuroscience Reports;2023-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3